Results for "consumer data right"
551-560 of 686 results for 'consumer data right'
ALRC recommends broad changes to Australia's corporate criminal responsibility regime
The ALRC is proposing an ambitious reform agenda to recalibrate the role that federal criminal law plays in the overall regulation of companies and better align corporate criminal liability with corporate culpability. Read our latest insight for our analysis on the report. ...
Retirement income covenant – one step closer to reality
The proposal for a specific covenant requiring super trustees to formulate, and give effect to, a retirement income strategy for members was first announced as part of the 2018-19 Federal Budget, and slated to be introduced into the Superannuation Industry (Supervision) Act 1993 (Cth) (SIS Act) by 1 July 2020. ...
The COVID-19 pandemic – what employers in Vietnam need to know
The Covid-19 pandemic is not only a health crisis in the global community, but has caused widespread economic disruption to all companies and governments around the world. As have governments in other countries, the Government of Vietnam has issued various restrictions and regulations ...
ASIC's New Document Production Guidelines
ASIC has released its new Document Production Guidelines, which govern how it expects electronic and hard copy records to be produced in response to compulsory notices. ...
Revised Banking Code of Practice, innovation at the ASX and other corporate law developments
Revised Banking Code of Practice; innovation at the ASX; and other corporate law developments. ...
FIRB changes to note from 1 July 2023
In this Insight, we outline and comment on the New Register and corresponding reporting obligations. ...
APRA consults on Hayne recommendation concerning end-to-end product responsibility – the right tool for the job?
APRA has announced a consultation on a proposal to create a new 'end-to-end product' responsibility within the Banking Executive Accountability Regime (BEAR). ...
Patent term extensions under siege: a new era of challenges for pharmaceutical patentees
A recent Federal Court decision has struck down a patent term extension granted to Novartis for its blockbuster heart failure drug Entresto. The decision in Novartis AG v Pharmacor Pty Limited follows a recent trend of successful challenges by generic pharmaceutical companies. ...
The ASX Listing Rules up for review but still fit for purpose: the case for retaining the existing policy settings on reverse takeovers
Merger transactions without a vote of the shareholders of each merger party are back in the headlines as a second deal sparks fresh tension and mounting calls from the Australian investment community ...
Regulatory scrutiny of private capital increases
Private capital is becoming a growing focus of regulators, both in Australia and internationally, given the ever-increasing flow of capital to the sector in recent years. ...